Zensun (Shanghai) Sci & Tech Co.

About:

a biopharmaceutical company focusing on the development of innovative bio-therapeutic.

Website: http://www.zensunus.com

Top Investors: China Venture Capital, SDIC Fund Management, Orient Securities, TFTR Investment, China Everbright Ivy Capital Investment

Description:

Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. They discover new medicines using novel disease specific targets and innovative technologies. The patented discoveries are then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not the symptoms. Zensun’s current pipeline covers cardiovascular disease treatment, anti-cancer drugs, and treatments for energy metabolism disorders.

Total Funding Amount:

507M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2000-01-01

Contact Email:

postmaster(AT)zensun.com

Founders:

Mingdong Zho

Number of Employees:

1-10

Last Funding Date:

2017-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai